Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    Data Compilation
    #PharmaFlow

    Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

    Stock Recap
    #PipelineProspector

    Menu

    Inderm

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 80Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/09/2025 SM BIOMED
    Malaysia
    		 Hiple Co., Ltd. 20120601-107-F-64-02(1) erythromycin 2015-11-17 SM Biomed SDN.BHD. Malaysia Lot 90, Sungai Petani Industrial Estate, 08000 Sungai Petani, Kedah, Malaysia (Erythromycin thiocyanate manufacturer: HEC Pharm co.ltd, No. 62, Binjiang Road, Yidu City, Hubei Province, China)